An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients

Completed · Phase 3

Conditions studied: Early Stage Parkinson's Disease

In brief

This is a multicenter, 6 months open label safety extension study for all patients who are willing and eligible to continue from the pivotal, double-blind S308.3.001 trial

Key facts

Study ID

NCT00332917

Run by

Solvay Pharmaceuticals

People needed

224

Starts

2007-02-01

Expected to finish

2008-07-01

Last updated by the study team

2009-01-26

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who have completed S308.3.001 trial

You may not qualify if…

• Patients with medically relevant abnormal findings (ECG, physical examination, AEs) at end of the maintenance phase (visit M6, week 24) of study S308.3.001

Where it is running

• Site 274 — Little Rock, Arkansas, United States
• Site 283 — Fountain Valley, California, United States
• Site 277 — La Jolla, California, United States
• Site 271 — San Francisco, California, United States
• Site 279 — Fort Lauderdale, Florida, United States
• Site 293 — Gainsville, Florida, United States
• Site 282 — Port Charlotte, Florida, United States
• Site 285 — Sunrise, Florida, United States
• Site 273 — Tampa, Florida, United States
• Site 290 — Chicago, Illinois, United States
• Site 280 — Kansas City, Kansas, United States
• Site 292 — Bingham Farms, Michigan, United States
• Site 275 — Traverse City, Michigan, United States
• Site 276 — St Louis, Missouri, United States
• Site 287 — St Louis, Missouri, United States
• Site 278 — Las Vegas, Nevada, United States
• Site 286 — Rochester, New York, United States
• Site 288 — Ashville, North Carolina, United States
• Site 289 — Charlotte, North Carolina, United States
• Site 294 — Toledo, Ohio, United States
• Site 281 — Pittsburgh, Pennsylvania, United States
• Site 291 — Warwick, Rhode Island, United States
• Site 272 — Houston, Texas, United States
• Site 270 — Bennington, Vermont, United States
• Site 284 — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.